Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected NSCLC Guideline Rapid Recommendation Update
An interview with Dr. Mark Kris from Memorial Sloan Kettering Cancer Center in New York, NY, author on "Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected...
14 Feb 202215min
Adjuvant Therapy for Stage II Colon Cancer Guideline Update
An interview with Dr. Nancy Baxter from the University of Melbourne in Melbourne, Australia, and Dr. Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston, MA, co-chairs on "Adjuvant Therapy ...
22 Des 202117min
Management of Stage III NSCLC Guideline
An interview with Dr. Megan Daly from University of California in Davis, California and Dr. Navneet Singh from the Postgraduate Institute of Medical Education & Research in Chandigarh, India, co-chair...
22 Des 202111min
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
An interview with Dr. David Schiff from the University of Virginia Medical Center in Charlottesville, VA, and Dr. Michael Vogelbaum from Moffitt Cancer Center in Tampa, FL, co-chairs on "Treatment for...
21 Des 202115min
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline
An interview with Dr. Jaishri Blakeley from Johns Hopkins University School of Medicine in Baltimore, MD, and Dr. Nimish Mohile from the University of Rochester Medical Center in Rochester, NY, co-cha...
13 Des 202116min
Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update
An interview with Dr. Sharon Giordano, co-chair on "Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guidel...
10 Des 20218min
Considerations for the Use of Steroids: Management of irAEs Guideline (Part 13)
An interview with Dr. Leslie Fecher from the University of Michigan Health System, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ...
16 Nov 20218min
Ocular Toxicities: Management of irAEs Guideline (Part 12)
An interview with Dr. Marc Ernstoff from the National Cancer Institute, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guidel...
15 Nov 20216min
